# Kojin Therapeutics: Research, Boston, United States

> Kojin Therapeutics: Kojin Therapeutics is a biotechnology company focused on developing small-molecule medicines that modulate ferroptosis, a specific type...

Source: https://millionrounds.com/startup/kojin-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Kojin Therapeutics

Kojin Therapeutics is a biotechnology company focused on developing small-molecule medicines that modulate ferroptosis, a specific type of cell death.

Funding reported Last round: Series A

Research Boston, United States

Company summary

- **Founded:** 2020 6 years old
- **Team:** 6 1 to 10 people
- **Funding reported:** $60M in dollars
- **Last round:** Series A Jun 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Kojin Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Kojin Therapeutics

Kojin Therapeutics is a biotechnology company focused on developing small-molecule medicines that modulate ferroptosis, a specific type of cell death.

Their innovative approach targets refractory cancers and inflammatory diseases, aiming to provide effective treatments for challenging medical conditions. The company is driven by a team of dedicated scientists who specialize in cell-state and ferroptosis biology. They foster a collaborative environment that encourages groundbreaking scientific advancements. Kojin Therapeutics is committed to creating therapies for patients with difficult-to-treat cancers, autoimmune diseases, and inflammatory conditions.

## What company datasets say Kojin Therapeutics raised

Funding, as reported

Reported in all **$60M** in dollars

Rounds **1**

Last round **Series A**

Last round size **$30M**

Last round date **Jun 2021**

Investors listed **8**

SEC Form D **$30M sold, 1 filing, last Jun 2021**

## Founders and team

From the SEC filings it signed: 2 on the team.

- **Susan Langer** President i
- **Amir Nashat** Treasurer and Secretary i

On the board, as filed i *Luba J. Greenwood* *Nagesh J. Mahanthappa* *Thomas J. Cahill*

## The company, in detail

What they build

Known for

biotechnology research italian pizza restaurants

Built with from their website

CloudFlare CloudFlare CDN Cloudflare DNS Google Search Console

- **Sector:** Research
- **Industry code:** NAICS 541714, 325412, SIC 8731, 2834
- **Region:** Massachusetts
- **Revenue:** $2.4M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/kojin-therapeutics)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Kojin Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)